@article{JTD20934,
author = {Ramon Andrade De Mello and Pedro Nazareth Aguiar and Hakaru Tadokoro and Tállita Meciany Farias-Vieira and Pedro Castelo-Branco and Gilberto de Lima Lopes and Daniel Humberto Pozza},
title = {MetaLanc9 as a novel biomarker for non-small cell lung cancer: promising treatments via a PGK1-activated AKT/mTOR pathway},
journal = {Journal of Thoracic Disease},
volume = {10},
number = {Suppl 17},
year = {2018},
keywords = {},
abstract = {Non-small cell lung cancer (NSCLC) is still challenging in terms of screening and treatment approaches (1). In Europe, Latin-America and US, NSCLC is among the most common diseases for both men and women (2).},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/20934}
}